Eagle Pharmaceuticals PE Ratio 2013-2019 | EGRX

Current and historical p/e ratio for Eagle Pharmaceuticals (EGRX) from 2013 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Eagle Pharmaceuticals PE ratio as of August 22, 2019 is 20.26.
Eagle Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-08-22 58.22 22.74
2019-03-31 50.49 $2.56 19.72
2018-12-31 40.29 $2.11 19.09
2018-09-30 69.33 $1.83 37.89
2018-06-30 75.66 $1.90 39.82
2018-03-31 52.69 $2.01 26.21
2017-12-31 53.42 $3.26 16.39
2017-09-30 59.64 $6.20 9.62
2017-06-30 78.89 $5.95 13.26
2017-03-31 82.94 $6.47 12.82
2016-12-31 79.34 $4.99 15.90
2016-09-30 70.00 $1.54 45.45
2016-06-30 38.79 $0.16 242.44
2016-03-31 40.50 $-1.17 0.00
2015-12-31 88.67 $0.20 443.35
2015-09-30 74.03 $-0.26 0.00
2015-06-30 80.86 $-0.26 0.00
2015-03-31 41.89 $0.06 698.17
2014-12-31 15.50 $-1.61 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.795B $0.213B
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.416B 28.09
Medtronic (MDT) Ireland $143.383B 20.13
Stryker (SYK) United States $81.532B 28.19
Boston Scientific (BSX) United States $59.201B 28.72
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $31.224B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.323B 18.13
Coloplast (CLPBY) Denmark $26.860B 42.88
Lonza Group Ag (LZAGY) Switzerland $26.257B 0.00
Terumo (TRUMY) Japan $23.378B 26.88
Smith & Nephew SNATS (SNN) United Kingdom $20.390B 0.00
ResMed (RMD) United States $19.442B 37.07
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.146B 54.39
Canopy Growth (CGC) Canada $9.436B 0.00
Insulet (PODD) United States $9.187B 544.39
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $6.980B 20.81
Haemonetics (HAE) United States $6.855B 51.73
Perrigo (PRGO) Ireland $6.412B 11.81
Aurora Cannabis (ACB) Canada $6.033B 59.30
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.550B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.748B 62.34
ICU Medical (ICUI) United States $3.408B 22.10
NuVasive (NUVA) United States $3.354B 26.74
Hutchison China MediTech (HCM) China $2.694B 0.00
Quidel (QDEL) United States $2.542B 25.24
Agios Pharmaceuticals (AGIO) United States $2.526B 0.00
National Vision Holdings (EYE) United States $2.185B 47.17
Cardiovascular Systems (CSII) United States $1.757B 0.00
Aphria (APHA) $1.569B 0.00
Phibro Animal Health (PAHC) United States $1.321B 19.79
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.030B 23.73
Omeros (OMER) United States $1.004B 0.00
NanoString Technologies (NSTG) United States $0.966B 0.00
PetIQ (PETQ) United States $0.929B 21.95
Lantheus Holdings (LNTH) United States $0.899B 23.64
Cerus (CERS) United States $0.762B 0.00
MacroGenics (MGNX) United States $0.749B 0.00
Quanterix (QTRX) United States $0.691B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.625B 118.74
LeMaitre Vascular (LMAT) United States $0.618B 36.66
OraSure Technologies (OSUR) United States $0.451B 20.86
Meridian Bioscience (VIVO) United States $0.415B 12.95
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.403B 0.00
United Health Products (UEEC) United States $0.392B 0.00
BioLife Solutions (BLFS) United States $0.391B 128.44
Utah Medical Products (UTMD) United States $0.348B 25.50
Zynex (ZYXI) United States $0.327B 34.76
Owens & Minor (OMI) United States $0.310B 9.28
Bovie Medical (APYX) United States $0.258B 0.00
Vapotherm (VAPO) United States $0.237B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.150B 0.00
Female Health (VERU) United States $0.119B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 21.24
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.012B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00